Big Gain For SAB Biotherapeutics Inc.
Thu, Apr 27, 2023 at 07:12 PM
SAB Biotherapeutics Inc. (SABS:NASDAQ) soared at $0.9, a gain of 24.7%. The stock appeared on our News Catalysts scanner on Wed, Apr 26, 2023 at 09:08 AM in the 'BIOTECH' category. From Thu, Apr 13, 2023, the stock recorded 40.00% Up Days and 63.64% Green Days
The stock spiked on Tue, Apr 18, 2023 at $1.45 with a volume of 37M+.
About SAB Biotherapeutics Inc. (SABS:NASDAQ)
SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company advancing a class of immunotherapies based on its human polyclonal antibodies.
Top 10 Gainers:
- Zhong Yang Financial Group Limited (TOP:NASDAQ), 197.62%
- Evelo Biosciences, Inc. (EVLO:NASDAQ), 101.1%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 54.59%
- ContraFect Corporation (CFRX:NASDAQ), 46.97%
- Silence Therapeutics Plc (SLN:NASDAQ), 34.08%
- Atomera Incorporated (ATOM:NASDAQ), 32.76%
- U Power Limited (UCAR:NASDAQ), 32.19%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 24.79%
- SAB Biotherapeutics Inc. (SABS:NASDAQ), 24.74%
- Immix Biopharma Inc. (IMMX:NASDAQ), 24.32%